Anika Therapeutics completes Parcus Medical acquisition

Written by Alan Condon | January 27, 2020 | Print  |

Anika Therapeutics on Jan. 24 acquired privately-held sports medicine company Parcus Medical.

Three insights:

1. Anika acquired all membership interests for $35 million with $60 million in potential incentives.

2. Parcus Medical's product portfolio facilitates surgeries of the shoulder, knee, hip and distal extremities.

3. The acquisition grants Anika access to the ASC market, which may lead to new revenue streams.

More articles on devices:
Bundled payments in spine: 12 key thoughts for 2020
Should pain management physicians perform endoscopic spine surgery? 8 spine specialists discuss
Medtronic CEO Omar Ishrak becomes Intel board chairman: 4 details

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers